883 results on '"Hellwig, Kerstin"'
Search Results
52. Glatiramer Acetate Or IFN-β Bridging Therapy in Women With Relapsing Multiple Sclerosis Planning a Pregnancy
53. Early postpartum treatment strategies and early postpartum relapses in women with active multiple sclerosis.
54. Safety of potential breast milk exposure to IFN-β or glatiramer acetate: One-year infant outcomes
55. Rituximab, MS, and pregnancy
56. Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder
57. Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders
58. Pregnancy and Infant Outcomes in Women Receiving Ocrelizumab for the Treatment of Multiple Sclerosis: Analysis of the Largest Available Outcomes Database
59. Ofatumumab in Breast Milk of Multiple Sclerosis Patients
60. Neuromyelitis optica spectrum disorders and pregnancy: relapse-preventive measures and personalized treatment strategies
61. Alemtuzumab as rescue therapy in a cohort of 50 relapsing–remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study
62. Multiple Sclerosis Disease Activity and Disability Following Cessation of Fingolimod for Pregnancy
63. Final Analysis of Pregnancy Outcomes Following Exposure to Dimethyl Fumarate in a Prospective International Registry (S31.004)
64. International Consensus on Smoldering Disease in Multiple Sclerosis using the Delphi Method (P11-3.013)
65. Diroximel Fumarate Pregnancy Outcomes in EVOLVE-MS-1 and Study Design of Diroximel Fumarate Prospective MS Pregnancy Exposure Registry (P9-3.003)
66. Real-world data on eculizumab treatment in NMOSD: high efficacy and potential challenges (P13-5.017)
67. Impact of Assisted Reproductive Technologies (ART) on Relapse Risk in Women with Multiple Sclerosis (S31.005)
68. Pregnancy Outcomes in Multiple Sclerosis patients with or without exposure to Disease Modifying Therapies during pregnancy (N2.003)
69. Schwangerschaft und Multiple Sklerose
70. Breastfeeding in Mothers with Multiple Sclerosis: The German Experience
71. Postpartum relapse risk in multiple sclerosis: a systematic review and meta-analysis
72. SARS-CoV-2 infection in chronic kidney disease patients with pre-existing dialysis: description across different pandemic intervals and effect on disease course (mortality)
73. Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions
74. Extensive immune reconstitution inflammatory syndrome in Fingolimod-associated PML: a case report with 7 Tesla MRI data
75. Postpartum relapse risk in multiple sclerosis: a systematic review and meta-analysis
76. Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study)
77. Humoral COVID-19 vaccine response in patients with NMOSD/MOGAD during anti-IL-6 receptor therapy compared to other immunotherapies
78. Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Diseases
79. Multiple sclerosis progression: time for a new mechanism-driven framework
80. Kinderwunsch, Schwangerschaft und Stillzeit: Prophylaxe und -therapie der Migräne umstellen
81. Additional file 1 of Disease severity in hospitalized COVID-19 patients: comparing routine surveillance with cohort data from the LEOSS study in 2020 in Germany
82. Covid-19 triage in the emergency department 2.0: how analytics and AI transform a human-made algorithm for the prediction of clinical pathways
83. sj-docx-1-msj-10.1177_13524585231151212 – Supplemental material for Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study)
84. Verträglichkeit von Interferonen
85. Motherhood choice in MS - feasibility testing and piloting of a web-based decision support tool and decision coaching programme
86. Cladribine and pregnancy in women with multiple sclerosis: The first cohort study
87. Effects of landscape elements on the distribution of the rare bumblebee species Bombus muscorum in an agricultural landscape
88. Modellierung zweier Zeit-abhängiger Risikofaktoren am Beispiel von Schwangerschaftsverläufen bei Multipler Sklerose
89. Multiple Sklerose in Schwangerschaft und Stillzeit
90. Multiple sclerosis in men: management considerations
91. Plasmapheresis and immunoadsorption in patients with steroid refractory multiple sclerosis relapses
92. Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study
93. Approaches to Understanding COVID‐19 and its Neurological Associations
94. Immune response in ofatumumab treated multiple sclerosis patients after SARS-CoV-2 vaccination
95. 151 Updated analysis of pregnancy outcomes for patients with MS in a dimethyl fumarate exposure registry
96. 2376 Immunoadsorption, therapeutic plasma exchange and pregnancy in women with multiple sclerosis – A case series from Germany
97. Ocrelizumab during pregnancy and lactation: Rationale and design of the MINORE and SOPRANINO studies in women with MS and their infants
98. Motherhood choice in multiple sclerosis (MoMS) development and piloting of patient-reported outcome measures
99. COVID-19 in patients with cirrhosis: insights from the multinational LEOSS registry
100. Natalizumab for multiple sclerosis: the dilemma of NOVA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.